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infections (8,9). This rate was even in
the lower range of values found
among HIV-infected heterosexual
persons in industrialized countries
(9%–27%) (2). Our results therefore
suggest that the high seroprevalence
rates of HIV and HCV in Africa will
not necessarily result in a high preva-
lence of HIV/HCV coinfection.
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Republic of Korea 
To the Editor: Amebic liver
abscess (ALA) is the most common
extraintestinal complication of ame-
bic infection. Although loss of cellular
immunity is thought to play a role in
infection by the pathogen, whether
HIV infection is also a risk factor for
invasive amebiasis is controversial
(1–3). ALA in HIV-infected patients
has not been well characterized,
although several case series have been
reported (2,4). We report the role of
HIV infection status in ALA in an area
where ALA is not endemic and the
clinical features of ALA in HIV-
infected patients.
All patients with ALA at Seoul
National University Hospital (SNUH)
from January 1990 through December
2005 were identified; some have been
previously reported (5). SNUH is a
1,600-bed, university-affiliated teach-
ing hospital and the largest referral
center for HIV/AIDS in the Republic
of Korea. The diagnostic criteria for
ALA were radiologic evidence of
intrahepatic abscess, trophozoites of
Entamoeba histolytica in fluid aspi-
rated from an abscess, or absence of
bacteria and fungi in aspirated
fluid and a titer ≥128 in an indirect
hemagglutination assay (IHA) for
E. histolytica.
Of 31 patients with ALA at
SNUH from 1990 through 2005, 10
(32%) were HIV positive. The propor-
tion of HIV-infected patients among
patients with ALA increased signifi-
cantly with time (linear-by-linear
association, p<0.001) (Figure). Of 10
patients from 1998 through 2005, 8
(80%) were HIV positive. Except for
2 patients with a history of travel to an
ALA-endemic area, 88% of the
patients were HIV positive.
Median age of the 10 HIV-posi-
tive patients with ALA was 34.5 years
(range 29–54 years); all patients were
male. Four had a homosexual orienta-
tion, 4 had a heterosexual orientation,
and 2 had an unknown sexual orienta-
tion. Fever (100%) was the most com-
mon symptom, and abdominal tender-
ness (90%) and diarrhea (50%) were
frequently observed. Median leuko-
cyte count was 9,000/mm3 (range
3,410–16,700/mm3), and median CD4
cell count was 279/mm3 (range
40–370/mm3). Eight patients had
abscesses in the right lobe of the liver
and 2 had abscesses in both lobes; 8
patients had 1 abscess and 2 had mul-
tiple abscesses. Median size of
abscesses was 7.25 cm (range 3–12
cm). In 5 patients, pleural effusion
was observed in chest radiographs.
IHA titer was >128 in 10 patients and
>512 in 8 patients. Median days to
defervescence was 2 (range 1–5
days). In 2 patients, perforation of the
abscess into the abdominal cavity was
a complication. No patients died or
had relapses.
Early in the AIDS pandemic,
some studies reported that the preva-
lence of invasive amebiasis was not
increased in patients with HIV infec-
tion (1,6). However, recent reports of
ALA associated with HIV infection
have increased. Studies in Taiwan
demonstrated that invasive amebiasis,
including ALA, is on the increase in
HIV-infected patients in disease-
endemic areas (2,7).
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Amebiasis was previously an
endemic disease in the Republic of
Korea. The positive rate for cysts of E.
histolytica/E. dispar in the general
population was 10% in the 1960s (5).
However, with improvements in sani-
tation, this rate decreased to 0.5% in
1993 and to nearly 0% in 2004 (8).
The present study showed that ALA in
association with HIV infection is
increasing in the Republic of Korea,
and that ALA in HIV-negative patients
has greatly decreased. In a study in the
United States, 38% of patients with
ALA with no history of travel to a
disease-endemic area were HIV posi-
tive (3). These results support the view
that ALA is an emerging parasite
infection in HIV-infected patients in
non–disease-endemic areas, as well as
in disease-endemic areas.
Immune suppression is an impor-
tant risk factor for ALA. In animal
studies, immune suppression after
thymectomy or splenectomy results in
an increased incidence of ALA (9).
Suppressed cellular immunity caused
by use of steroids and malnourish-
ment predispose to fatal amebiasis
(10). In the present study, 90% of
patients had CD4 cell counts
<350/mm3, which implies that
immune suppression by HIV infection
may be another risk factor for ALA.
Only 2 patients with pyogenic
liver abscess were observed during
the study. In these patients, pyogenic
liver abscess was diagnosed, despite
negative cultures for bacteria and
fungi, because trophozoites of E. his-
tolytica were not demonstrated in
aspirated pus, and results of IHA for
amebiasis were negative. However,
we cannot exclude amebic liver
abscess in these 2 patients because
IHA test results can be negative in
HIV-infected patients (2).
This study suggests that ALA is
an emerging parasite infection in
HIV-infected patients even in areas
where the disease is not endemic.
ALA should be considered in HIV-
infected patients with space-occupy-
ing lesions in the liver, and HIV
screening is strongly recommended in
patients in areas where ALA is not
endemic, especially those with no his-
tory of travel to a disease-endemic
area.
Wan Beom Park,* 
Pyoeng Gyun Choe,* Jae Hyun Jo,*
Sung-Han Kim,* Ji Hwan Bang,*
Hong Bin Kim,* Nam Joong Kim,*
Myoung-don Oh,* 
and Kang Won Choe*
*Seoul National University College of
Medicine, Seoul, Republic of Korea
References
1. Jessurun J, Barron-Rodriguez LP,
Fernandez-Tinoco G, Hernandez-Avila M.
The prevalence of invasive amebiasis is not
increased in patients with AIDS. AIDS.
1992;6:307–9.
2. Hung CC, Chen PJ, Hsieh SM, Wong JM,
Fang CT, Chang SC, et al. Invasive amoe-
biasis: an emerging parasitic disease in
patients infected with HIV in an area
endemic for amoebic infection. AIDS.
1999;13:2421–8.
3. Seeto RK, Rockey DC. Amebic liver
abscess: epidemiology, clinical features,
and outcome. West J Med. 1999;170:
104–9.
4. Wiwanitkit V. A note on clinical presenta-
tions of amebic liver abscess: an overview
from 62 Thai patients. BMC Fam Pract.
2002;3:13.
5. Oh MD, Lee K, Kim E, Lee S, Kim N, Choi
H, et al. Amoebic liver abscess in HIV-
infected patients. AIDS. 2000;14:1872–3.
6. Reed SL, Wessel DW, Davis CE.
Entamoeba histolytica infection and AIDS.
Am J Med. 1991;90:269–71.
7. Liu CJ, Hung CC, Chen MY, Lai YP, Chen
PJ, Huang SH, et al. Amebic liver abscess
and human immunodeficiency virus infec-
tion: a report of three cases. J Clin
Gastroenterol. 2001;33:64–8.
8. Chai JY, Park JH, Guk SM, Kim HJ, Kim
JL, Gu YS, et al. Status of intestinal parasite
infections among 4,137 residents from
provinces nationwide and metropolitan
areas in the Republic of Korea (2004).
Journal of Infection and Chemotherapy.
2006;38:198–203.
9. Ghadirian E, Meerovitch E. Effect of
immunosuppression on the size and metas-
tasis of amoebic liver abscesses in ham-
sters. Parasite Immunol. 1981;3:329–38.
10. Eisert J, Hannibal JE, Sanders SL. Fatal
amebiasis complicating corticosteroid man-
agement of pemphigus vulgaris. N Engl J
Med. 1959;261:843–5.
Address for correspondence: Kang Won Choe,
Department of Internal Medicine, Seoul
National University College of Medicine, 28
Yeongun-dong, Chongro-gu, Seoul, Republic
of Korea, 110-744; email: choekw@snu.ac.kr
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 3, March 2007 517
Figure. Number of cases of amebic liver abscess in patients with and without HIV infec-
tion at Seoul National University Hospital, Republic of Korea, 1990–2005. 
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